A recently approved group of drugs - immune checkpoint inhibitors - can boost the body's ability to eliminate a tumor and ...

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study ...

UCLA researchers have developed a CAR-NKT cell therapy that has been more effective than current immunotherapies at fighting ...

Immunotherapies, such as the blockbuster immune checkpoint inhibitor drug Keytruda (pembrolizumab), work by keeping cancer cells from suppressing a patient’s immune system and thus allowing the immune ...

Current guidelines exclude a large number of people who could have their cancer detected earlier, according to a new study.

Two teams discover how small cell lung cancer hijacks neural pathways to proliferate faster, especially to the brain. Common ...

Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...

Lung cancer stands as a formidable health challenge, claiming more lives globally than any other type of cancer. This ...

The process of TIL therapy is complex and requires the coordination of multiple specialties at authorized treatment centers, ...

Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors ...

After her shocking lung cancer diagnosis, the late Susan Wojcicki dedicated herself to fighting the disease and looking for ...

Approximately 20% of new lung cancer diagnoses occur in nonsmokers in the U.S., according to The Ohio State University ...